期刊文献+

冠心病患者超敏C反应蛋白的检测及意义 被引量:2

下载PDF
导出
摘要 目的:探讨血清超敏C反应蛋白(hs-CRP)的含量变化在冠心病中的临床应用。方法:随机选取75例冠心病患者作为观察组,其中急性心肌梗死(AMI)、不稳定型心绞痛(UAP)、稳定型心绞痛(SAP)各25例,并选取20例健康人作为对照组。采用免疫透射比浊法检测两组患者血清中hs-CRP含量,并分析比较观察组治疗前后hs-CRP含量的变化。结果:治疗前AMI、UAP、SAP3组的血清hs-CRP含量(3.25±1.24、6.67±2.73、12.74±4.76)显著高于对照组(0.97±0.74);治疗后AMI、UAP、SAP3组的血清hs-CRP含量(1.92±0.83、3.62±1.50、7.25±3.14)显著低于各组治疗前水平,结果均具有统计学意义(P<0.05)。结论:血清hs-CRP水平的变化与冠心病的发生、发展密切相关,对其检测有助于冠心病患者的诊断、疗效观察及预后的判断。
作者 李国芬
出处 《中国社区医师(医学专业)》 2011年第12期193-193,共1页
  • 相关文献

参考文献6

二级参考文献31

共引文献18

同被引文献28

  • 1马梅,齐新,何丽华,张东玲,孟东,刘克强.血清超敏C反应蛋白对冠心病患者诊断的临床意义[J].中国心血管病研究,2007,5(7):527-530. 被引量:13
  • 2Li JJ ,Yang P, Liu J, et al. Impact of 10 mg rosuvastatin daily m alternate-day on lipid profile and inflammatory markers [ J ]. Clin Chim Acta,2012,413 ( 1 - 2 ) : 139 - 142.
  • 3McNeil M, Buth K, Brydie A, et al. The impact of diffuseness of coronary artery disease on the outcomes of patients undergoing primary and reoperative coronary artery bypass grafting[ J]. Eur J Cardio-thorac Surg,2007,31 (5) : 827 - 833.
  • 4Ferri:res J. Effects on coronary atherosclerosis by targeting low- density lipoprotein cholesterol withstatins [ J ]. Am J Cardiovasc Drugs,2009,9(2) : 109 - 115.
  • 5Sviridov D, Hoang A, Ooi E, et al. Indices of reverse cholesterol transport in subjects with metabolic syndrome after treatment with rosuvastatin [ J ]. Atherusclerosis, 2008,197 ( 2 ) : 732 - 739.
  • 6Hong MK, Park DW, Lee CW,et al. Effects of statin treatments oncoronary plaques assessed by volumetric virtual histology intravas- cular ultrasound analysis [ J ]. JACC,2009,2 (7) :697 - 688.
  • 7Sipahi I, Tuzcu EM, Schoenhagen P,et al. Paradoxical increase in lumen size during progression of coronary atherosclerosis : observa- tions from the REVERSAL trial [ J ]. Atherosclerosis, 2006,189 ( 1 ) :229 - 235.
  • 8Takayama T, Him T, Yamagishi M, et aL Effect of rosuvastatin on coronary atheroma in stable coronary artery disease: muhicenter coronary atheroselerosis study measuring effects of rosuvastatin u- sing.intravascular ultrasound in Japanese subjects ( COSMOS ) [J]. Cire J,2009,73 (11) :2110 -2117.
  • 9Ballantyne CM, Davidson MH, Setze CM, et al. Effects of combi- nation therapy with rosuvastatin and fenofibric acid in patients with mixed dyslipidemia and high-sensitivity C-reactive protein ( I> 2 rag/L)[J]. J Clin Lipidol,2011,5(5) :401 -407.
  • 10Raseh U, Tatzher F, Budinshy A, et al. Reduction of oxidative stress and modulation of autoantibodies against modified low-den- sity lipoprotein after rosuvastatin therapy[ J]. Br J Clin Pharma- col,2006,61 (3) :262 - 274.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部